4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

978.18p
   
  • Change Today:
    -6.82p
  • 52 Week High: 1,560.00
  • 52 Week Low: 960.00
  • Currency: UK Pounds
  • Shares Issued: 15.51m
  • Volume: 10
  • Market Cap: £151.71m

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
86.70% above the market average86.70% above the market average86.70% above the market average86.70% above the market average86.70% above the market average
48.39% above the sector average48.39% above the sector average48.39% above the sector average48.39% above the sector average48.39% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
93.36% above the market average93.36% above the market average93.36% above the market average93.36% above the market average93.36% above the market average
84.00% above the sector average84.00% above the sector average84.00% above the sector average84.00% above the sector average84.00% above the sector average
Price Book Ratio
83.27% below the market average83.27% below the market average83.27% below the market average83.27% below the market average83.27% below the market average
48.72% below the sector average48.72% below the sector average48.72% below the sector average48.72% below the sector average48.72% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
80.73% below the market average80.73% below the market average80.73% below the market average80.73% below the market average80.73% below the market average
60.87% below the sector average60.87% below the sector average60.87% below the sector average60.87% below the sector average60.87% below the sector average
Price Chg 3m
84.42% below the market average84.42% below the market average84.42% below the market average84.42% below the market average84.42% below the market average
69.57% below the sector average69.57% below the sector average69.57% below the sector average69.57% below the sector average69.57% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
81.15% below the market average81.15% below the market average81.15% below the market average81.15% below the market average81.15% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Momentum 20
95.43% below the market average95.43% below the market average95.43% below the market average95.43% below the market average95.43% below the market average
80.95% below the sector average80.95% below the sector average80.95% below the sector average80.95% below the sector average80.95% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
93.91% below the market average93.91% below the market average93.91% below the market average93.91% below the market average93.91% below the market average
75% below the sector average75% below the sector average75% below the sector average75% below the sector average75% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
54.56% below the market average54.56% below the market average54.56% below the market average54.56% below the market average54.56% below the market average
8.7% below the sector average8.7% below the sector average8.7% below the sector average8.7% below the sector average8.7% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
82.12% below the market average82.12% below the market average82.12% below the market average82.12% below the market average82.12% below the market average
56.25% below the sector average56.25% below the sector average56.25% below the sector average56.25% below the sector average56.25% below the sector average
Operating Profit Loss
85.06% below the market average85.06% below the market average85.06% below the market average85.06% below the market average85.06% below the market average
52.17% below the sector average52.17% below the sector average52.17% below the sector average52.17% below the sector average52.17% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
8.65% above the market average8.65% above the market average8.65% above the market average8.65% above the market average8.65% above the market average
30.23% above the sector average30.23% above the sector average30.23% above the sector average30.23% above the sector average30.23% above the sector average
Cash
46.24% above the market average46.24% above the market average46.24% above the market average46.24% above the market average46.24% above the market average
55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
17.73% above the market average17.73% above the market average17.73% above the market average17.73% above the market average17.73% above the market average
27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average
Buys 1y
70.72% above the market average70.72% above the market average70.72% above the market average70.72% above the market average70.72% above the market average
57.58% above the sector average57.58% above the sector average57.58% above the sector average57.58% above the sector average57.58% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

4basebio Market Data

Currency UK Pounds
Share Price 978.18p
Change Today -6.82p
% Change -0.69 %
52 Week High 1,560.00
52 Week Low 960.00
Volume 10
Shares Issued 15.51m
Market Cap £151.71m

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
65.88% below the market average65.88% below the market average65.88% below the market average65.88% below the market average65.88% below the market average
8.7% below the sector average8.7% below the sector average8.7% below the sector average8.7% below the sector average8.7% below the sector average
Price Trend
31% below the market average31% below the market average31% below the market average31% below the market average31% below the market average
4.35% above the sector average4.35% above the sector average4.35% above the sector average4.35% above the sector average4.35% above the sector average
Income Not Available
Growth
58.55% above the market average58.55% above the market average58.55% above the market average58.55% above the market average58.55% above the market average
68.75% above the sector average68.75% above the sector average68.75% above the sector average68.75% above the sector average68.75% above the sector average

4basebio Dividends

No dividends found

Trades for 08-Jul-2025

Time Volume / Share Price
08:25 1 @ 960.00p
08:25 0 @ 1,040.00p
08:25 1 @ 1,020.00p
08:25 3 @ 960.00p
08:25 2 @ 1,020.00p

4basebio Key Personnel

CEO Heikki Lanckriet
CFO David John Roth

Top of Page